Riskpilot← Back to searchSign inGet full accessCTR Translational Next AB
ABIn liquidationOrg 5592398936UppsalaResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20200 employees
Revenue 2024
SEK -1
EBITDA margin
117800.0%
+97% vs 2023
Equity ratio
76.1%
Financial strength
Net profit 2024
SEK -2K
0 employees
| Revenue | SEK -1 | — |
| EBITDA | SEK -1K | +97% |
| Net profit | SEK -2K | — |
| Total assets | SEK 158K | -19% |
| Equity | SEK 120K | -2% |
| Employees | 0 | — |
Legal name
CTR Translational Next AB
Org number
5592398936
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
31 januari 2020
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Aktiebolaget skall bedriva förvaltning av värdepapper samt därmed jämförlig verksamhet.
Address
Uppsala
Email
stefan@consulterna.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 842 | 7 786 | 1 853 | 0 | −0 |
| Staff expenses | — | — | — | — | 1 |
| EBITDA | −3 038 | −2 503 | −138 | −43 | −1 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | — |
| EBIT | −3 038 | −2 503 | −138 | −43 | −1 |
| Net financials | — | — | — | −1 | −0 |
| Profit before tax | −4 | 3 | 1 | 0 | −2 |
| Tax | −0 | −3 | −1 | −0 | — |
| Net profit | −4 | 0 | 0 | 0 | −2 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 695 | 6 894 | 5 836 | 196 | 158 |
| Equity | 5 021 | 5 022 | 5 022 | 122 | 120 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 673 | 1 873 | 815 | 74 | 38 |
| Total debt | 673 | 1 873 | 815 | 74 | 38 |
EBITDA margin
-117800.0%
This company
15.8%
Market median
-745670% vs market
20202024
Equity ratio
76.1%
This company
38.2%
Market median
+99% vs market
20202024
Return on equity
-1.3%
This company
18.4%
Market median
-107% vs market
20202024
Net profit margin
-161900.0%
This company
8.1%
Market median
-1998865% vs market
20202024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.31×
This company
0.62×
Market median
+50% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LJ | Audit | 2023 | — | — |
SA Chief Auditor | Chief Auditor | 2021 | — | — |
CS Liquidator | Liquidator | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2025 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2025 | — | — | |
| Deputy Board Member | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Center for Translational Research Sweden AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Center for Translational Research Sweden AB
CTR Translational Next AB Board members of CTR Translational Next AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Johan Valfrid Grahn | Audit | 0 companies |
| Stéphanie Anna Chantal Ljungberg | Chief Auditor | 0 companies |
| Curt Stefan Sjöö | Liquidator | 0 companies |
| Emma Sofia Ågren | Deputy Board Member | 0 companies |
| Bengt Erik Dahlström | Board of Directors | 0 companies |
| Karin Judith Meyer | Chairman | 0 companies |
| Mats Peter Lindquist | Board of Directors | 0 companies |
| Bengt Stefan Samuelsson | Board of Directors | 0 companies |
| Bror Folke Sjöberg | Deputy Board Member | 0 companies |